TREE NEWS reports: As innovative drug BD deals stay active, pharma firms’ R&D funding grows, boosting willingness to pay for external R&D services. CRO companies report a ‘volume and price rise’ in orders, with project quotes rising. The sector may accelerate its recovery in the second half.
CRO Sector May Accelerate Recovery in H2 as Innovative Drug Projects See Rising Quotes
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
Crypto-related US stocks dip 0.08%, week up 12.05%
1h ago
Israel Strikes Southern Lebanon in Response to Hezbollah Drone
2h ago
Nasdaq Golden Dragon China Index Rises 0.8% Friday, Down 2.5% Week
3h ago
US Jobs Report Knocks Bitcoin Below $81,000
3h ago
Pineapple Financial to tokenize $10B mortgages on Injective
3h ago
FinCEN: $13B in crypto scams tied to non-US operations